United States Emphysema Drug Market Report 2018

January 2018 | 99 pages | ID: U8079728450EN
QYResearch

Abstracts

In this report, the United States Emphysema Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Emphysema Drug in these regions, from 2013 to 2025 (forecast).

United States Emphysema Drug market competition by top manufacturers/players, with Emphysema Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Angion Biomedica Corp.
• ProMetic Life Sciences Inc.
• rEVO Biologics, Inc.
• SATT North SAS
• TGV-Laboratories

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• BB-3
• EDO-66
• MG-53
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Emphysema Drug Market Report 2018

1 EMPHYSEMA DRUG OVERVIEW

1.1 Product Overview and Scope of Emphysema Drug
1.2 Classification of Emphysema Drug by Product Category
  1.2.1 United States Emphysema Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Emphysema Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 BB-3
  1.2.4 EDO-66
  1.2.5 MG-53
  1.2.6 Others
1.3 United States Emphysema Drug Market by Application/End Users
  1.3.1 United States Emphysema Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Emphysema Drug Market by Region
  1.4.1 United States Emphysema Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Emphysema Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Emphysema Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Emphysema Drug Status and Prospect (2013-2025)
  1.4.5 New England Emphysema Drug Status and Prospect (2013-2025)
  1.4.6 The South Emphysema Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Emphysema Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Emphysema Drug (2013-2025)
  1.5.1 United States Emphysema Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Emphysema Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES EMPHYSEMA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Emphysema Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Emphysema Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Emphysema Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Emphysema Drug Market Competitive Situation and Trends
  2.4.1 United States Emphysema Drug Market Concentration Rate
  2.4.2 United States Emphysema Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Emphysema Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES EMPHYSEMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Emphysema Drug Sales and Market Share by Region (2013-2018)
3.2 United States Emphysema Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Emphysema Drug Price by Region (2013-2018)

4 UNITED STATES EMPHYSEMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Emphysema Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Emphysema Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Emphysema Drug Price by Type (2013-2018)
4.4 United States Emphysema Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES EMPHYSEMA DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Emphysema Drug Sales and Market Share by Application (2013-2018)
5.2 United States Emphysema Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES EMPHYSEMA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Angion Biomedica Corp.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Emphysema Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 ProMetic Life Sciences Inc.
  6.2.2 Emphysema Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 rEVO Biologics, Inc.
  6.3.2 Emphysema Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 SATT North SAS
  6.4.2 Emphysema Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 SATT North SAS Emphysema Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 TGV-Laboratories
  6.5.2 Emphysema Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 EMPHYSEMA DRUG MANUFACTURING COST ANALYSIS

7.1 Emphysema Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Emphysema Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Emphysema Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Emphysema Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES EMPHYSEMA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Emphysema Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Emphysema Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Emphysema Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Emphysema Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Emphysema Drug
Figure United States Emphysema Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Emphysema Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure BB-3 Product Picture
Figure EDO-66 Product Picture
Figure MG-53 Product Picture
Figure Others Product Picture
Figure United States Emphysema Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Emphysema Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Emphysema Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Emphysema Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Emphysema Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Emphysema Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Emphysema Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Emphysema Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Emphysema Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Emphysema Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Emphysema Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Emphysema Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Emphysema Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Emphysema Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Emphysema Drug Sales Share by Players/Suppliers
Figure 2017 United States Emphysema Drug Sales Share by Players/Suppliers
Figure United States Emphysema Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Emphysema Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Emphysema Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Emphysema Drug Revenue Share by Players/Suppliers
Figure 2017 United States Emphysema Drug Revenue Share by Players/Suppliers
Table United States Market Emphysema Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Emphysema Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Emphysema Drug Market Share of Top 3 Players/Suppliers
Figure United States Emphysema Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Emphysema Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Emphysema Drug Product Category
Table United States Emphysema Drug Sales (K Pcs) by Region (2013-2018)
Table United States Emphysema Drug Sales Share by Region (2013-2018)
Figure United States Emphysema Drug Sales Share by Region (2013-2018)
Figure United States Emphysema Drug Sales Market Share by Region in 2017
Table United States Emphysema Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Emphysema Drug Revenue Share by Region (2013-2018)
Figure United States Emphysema Drug Revenue Market Share by Region (2013-2018)
Figure United States Emphysema Drug Revenue Market Share by Region in 2017
Table United States Emphysema Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Emphysema Drug Sales (K Pcs) by Type (2013-2018)
Table United States Emphysema Drug Sales Share by Type (2013-2018)
Figure United States Emphysema Drug Sales Share by Type (2013-2018)
Figure United States Emphysema Drug Sales Market Share by Type in 2017
Table United States Emphysema Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Emphysema Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Emphysema Drug by Type (2013-2018)
Figure Revenue Market Share of Emphysema Drug by Type in 2017
Table United States Emphysema Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Emphysema Drug Sales Growth Rate by Type (2013-2018)
Table United States Emphysema Drug Sales (K Pcs) by Application (2013-2018)
Table United States Emphysema Drug Sales Market Share by Application (2013-2018)
Figure United States Emphysema Drug Sales Market Share by Application (2013-2018)
Figure United States Emphysema Drug Sales Market Share by Application in 2017
Table United States Emphysema Drug Sales Growth Rate by Application (2013-2018)
Figure United States Emphysema Drug Sales Growth Rate by Application (2013-2018)
Table Angion Biomedica Corp. Basic Information List
Table Angion Biomedica Corp. Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Angion Biomedica Corp. Emphysema Drug Sales Growth Rate (2013-2018)
Figure Angion Biomedica Corp. Emphysema Drug Sales Market Share in United States (2013-2018)
Figure Angion Biomedica Corp. Emphysema Drug Revenue Market Share in United States (2013-2018)
Table ProMetic Life Sciences Inc. Basic Information List
Table ProMetic Life Sciences Inc. Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ProMetic Life Sciences Inc. Emphysema Drug Sales Growth Rate (2013-2018)
Figure ProMetic Life Sciences Inc. Emphysema Drug Sales Market Share in United States (2013-2018)
Figure ProMetic Life Sciences Inc. Emphysema Drug Revenue Market Share in United States (2013-2018)
Table rEVO Biologics, Inc. Basic Information List
Table rEVO Biologics, Inc. Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure rEVO Biologics, Inc. Emphysema Drug Sales Growth Rate (2013-2018)
Figure rEVO Biologics, Inc. Emphysema Drug Sales Market Share in United States (2013-2018)
Figure rEVO Biologics, Inc. Emphysema Drug Revenue Market Share in United States (2013-2018)
Table SATT North SAS Basic Information List
Table SATT North SAS Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure SATT North SAS Emphysema Drug Sales Growth Rate (2013-2018)
Figure SATT North SAS Emphysema Drug Sales Market Share in United States (2013-2018)
Figure SATT North SAS Emphysema Drug Revenue Market Share in United States (2013-2018)
Table TGV-Laboratories Basic Information List
Table TGV-Laboratories Emphysema Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure TGV-Laboratories Emphysema Drug Sales Growth Rate (2013-2018)
Figure TGV-Laboratories Emphysema Drug Sales Market Share in United States (2013-2018)
Figure TGV-Laboratories Emphysema Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Emphysema Drug
Figure Manufacturing Process Analysis of Emphysema Drug
Figure Emphysema Drug Industrial Chain Analysis
Table Raw Materials Sources of Emphysema Drug Major Players/Suppliers in 2017
Table Major Buyers of Emphysema Drug
Table Distributors/Traders List
Figure United States Emphysema Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Emphysema Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Emphysema Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Emphysema Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Emphysema Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Emphysema Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Emphysema Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Emphysema Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Emphysema Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Emphysema Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Emphysema Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Emphysema Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Emphysema Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources